Document is current
Any future updates will be listed below
-
Authors
Falso, Silvia
Spagni, Gregorio
Monte, Gabriele
Marini, Sofia
Marini, Martina
Alboini, Paolo Emilio
Damato, Valentina
Evoli, Amelia https://orcid.org/0000-0003-0282-8787
Iorio, Raffaele
-
Funding
Funding for this research was provided by:
Rare Diseases Clinical Research Network (NIH U54 NS115054)
- License Information
-
More Information
Article History
Received: 1 December 2025
Revised: 30 January 2026
Accepted: 1 February 2026
First Online: 23 March 2026
Declarations
:
: S.F. has received speaker honoraria from Alexion, Argenx, UCB. G.S. has received public speaking honoraria and/or consultation fees from Argenx, Alexion, and AMGEN. S.M. has received speaker honoraria from Alexion and UCB. P.E.M. has received support for attending scientific meetings and speaker honoraria from Amgen, UCB, Alexion, Argenx. V.D. has received public speaking honoraria and compensation for advisory boards and/or consultation fees from UCB, Alexion, Dianthus, and Roche. A.E. has received consultancy fees and speaker honoraria from Grifols, UCB, Alexion. R.I. has received consultancy fees and speaker honoraria from Alexion, Amgen, Argenx, Johnson&Johnson, Merck, UCB and Dianthus Therapeutics. The remaining authors have no conflicts of interest.
